Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06701331 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06701331
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-22
- Primary completion
- 2027-01-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.